26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

• Vikram Arya, PhD, FCP - Food and Drug Administration, United States
• Kristina Brooks, PharmD - University of Colorado Anschutz Medical Campus, United States
• Andrea Calcagno, MD, DTM&H - University of Turin, Italy
• Su-Young Choi, PharmD, PhD - Food and Drug Administration, United States
• Angela Colbers, PhD - Radboud University Medical Center, the Netherlands
• Paolo Denti, PhD - University of Cape Town, South Africa
• Tanuja N. Gengiah, B.Pharm, MClinPharm, Ms(Epi), PhD - Centre for the AIDS Programme of Research (CAPRISA) & University of KwaZulu-Natal, South Africa
• Mohammed Lamorde, MD - Infectious Diseases Institute, Uganda
• Minh Patrick Lê, PhD - Hôpital Bichat-Claude Bernard, France
• Lawrence Lee, MBBS, PhD - National University of Singapore, Singapore
• Catia Marzolini, PharmD, PhD - University Hospital Basel, Switzerland & University of Liverpool, United Kingdom
• Steve Taylor, MRCP, PhD - Birmingham Heartlands Hospital, United Kingdom
• Catriona Waitt, MBChB, PhD - University of Liverpool, United Kingdom
• Julie Dumond, Pharm.D., M.S. - UNC Eshelman School of Pharmacy,United States

The members of Scientific Committee are hand-picked by the Organizing Committee and the workshop secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Academic Advisory Board

• David Back, PhD - University of Liverpool, United Kingdom
• Terrence Blaschke, MD - Stanford University School of Medicine, United States
• Marta Boffito, MD, PhD, FRCP - Chelsea and Westminster Hospital London, United Kingdom
• David Burger, MD, PhD - Radboud University Medical Center, the Netherlands
• Giovanni Di Perri, MD, PhD - University of Torino, Italy
• Courtney Fletcher, PharmD - University of Nebraska Medical Center, United States
• Charles Flexner, MD - Johns Hopkins University, United States
• Angela Kashuba, PharmD - University of North Carolina at Chapel Hill, United States
• Jürgen Rockstroh, MD - University of Bonn, Germany
• Jonathan Schapiro, MD - National Hemophilia Center, Sheba Medical Center, Israel

The members of the Academic Advisory Board (AAB) are former members of the OC and remain active the in planning of the program for the next year. Members of the current OC are selected from this group.

Industry Liaison Board

• Wei Liu - AbbVie
• Thomas Kakuda - Janssen, Pharmaceutical Companies of Johnson and Johnson
• Xiao-Jian Zhou - ​​​​​​Atea Pharmaceuticals
• Simon Portsmouth - Shionogi

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.